Neursantys
PrivateLast Round
Grant
Jul 27, 2024
Est. Valuation
$3.12M
Total Funding Raised
$444,100
Momentum Score
100 /100
Company Overview
Neursantys is a medical devices company developing non-invasive bioelectronic devices and treatments to address neuromotor conditions caused by aging, trauma, or disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Sensors, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neursantys Comps
Public and private peers based on sector, stage, and business model.
Neursantys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 27, 2024 | ||||
| Grant | Jun 11, 2024 | ||||
| Grant | Apr 28, 2023 | ||||
| Seed | Mar 14, 2023 | ||||
| Grant | Jun 30, 2022 | ||||
Grant | May 25, 2022 |
Neursantys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| mHUB Ventures | Accelerator |
| National Institute on Aging | Grant |
| Canadian Space Agency | Grant |
| Edward-Elmhurst Health Venture Capital | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 46% MoM.
- Sep 17, 2025
Neursantys won "top honors" in an unspecified category for its pilot study of the NEURVESTA Vestibular Stimulation Therapy.
Neursantys Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neursantys's valuation, stock price, and market status.
